These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 3358644

  • 1. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD.
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [Abstract] [Full Text] [Related]

  • 2. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP, Pecknold JC, Kuch K.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 May; 11(2-3):105-13. PubMed ID: 3628823
    [Abstract] [Full Text] [Related]

  • 3. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL.
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [Abstract] [Full Text] [Related]

  • 4. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M.
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [Abstract] [Full Text] [Related]

  • 5. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
    Ballenger JC, Burrows GD, DuPont RL, Lesser IM, Noyes R, Pecknold JC, Rifkin A, Swinson RP.
    Arch Gen Psychiatry; 1988 May; 45(5):413-22. PubMed ID: 3282478
    [Abstract] [Full Text] [Related]

  • 6. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE, Greenberg HS.
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [Abstract] [Full Text] [Related]

  • 7. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC, Swinson RP, Kuch K, Lewis CP.
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [Abstract] [Full Text] [Related]

  • 8. The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.
    Marks IM, De Albuquerque A, Cottraux J, Gentil V, Greist J, Hand I, Liberman RL, Relvas JS, Tobeña A, Tyrer P.
    Arch Gen Psychiatry; 1989 Jul; 46(7):668-72. PubMed ID: 2660772
    [No Abstract] [Full Text] [Related]

  • 9. Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder.
    O'Sullivan GH, Noshirvani H, Başoğlu M, Marks IM, Swinson R, Kuch K, Kirby M.
    Br J Psychiatry; 1994 Jul; 165(1):79-86. PubMed ID: 7802851
    [Abstract] [Full Text] [Related]

  • 10. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    Charney DS, Woods SW.
    J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
    [Abstract] [Full Text] [Related]

  • 11. Alprazolam in the treatment of panic attack patients with and without major depression.
    Pyke RE, Kraus M.
    J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
    [Abstract] [Full Text] [Related]

  • 12. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E, Rickels K, Weiss S, Zavodnick S.
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [Abstract] [Full Text] [Related]

  • 13. Treatment of panic disorder and agoraphobia with clonazepam.
    Spier SA, Tesar GE, Rosenbaum JF, Woods SW.
    J Clin Psychiatry; 1986 May; 47(5):238-42. PubMed ID: 3700341
    [Abstract] [Full Text] [Related]

  • 14. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
    Sheehan DV, Coleman JH, Greenblatt DJ, Jones KJ, Levine PH, Orsulak PJ, Peterson M, Schildkraut JJ, Uzogara E, Watkins D.
    J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
    [Abstract] [Full Text] [Related]

  • 15. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
    Schweizer E, Patterson W, Rickels K, Rosenthal M.
    Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
    [Abstract] [Full Text] [Related]

  • 16. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL.
    J Psychiatr Res; 1990 Aug; 24 Suppl 2():27-41. PubMed ID: 1980697
    [Abstract] [Full Text] [Related]

  • 17. Alprazolam in the treatment of panic disorders.
    Liebowitz MR, Fyer AJ, Gorman JM, Campeas R, Levin A, Davies SR, Goetz D, Klein DF.
    J Clin Psychopharmacol; 1986 Feb; 6(1):13-20. PubMed ID: 2869059
    [Abstract] [Full Text] [Related]

  • 18. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR.
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [Abstract] [Full Text] [Related]

  • 19. Diazepam and propranolol in panic disorder and agoraphobia.
    Noyes R, Anderson DJ, Clancy J, Crowe RR, Slymen DJ, Ghoneim MM, Hinrichs JV.
    Arch Gen Psychiatry; 1984 Mar; 41(3):287-92. PubMed ID: 6367691
    [Abstract] [Full Text] [Related]

  • 20. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
    Tesar GE, Rosenbaum JF, Pollack MH, Otto MW, Sachs GS, Herman JB, Cohen LS, Spier SA.
    J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.